Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Head and Neck Neoplasms 15Squamous Cell Carcinoma of Head and Neck 8Radiation Injuries 5Xerostomia 3Drug-Related Side Effects and Adverse Reactions 3Salivary Gland Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms, Unknown Primary 2Nasopharyngeal Neoplasms 2Mucositis 2Mouth Neoplasms 2Lung Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Kidney Neoplasms 1Esthesioneuroblastoma, Olfactory 1Deglutition Disorders 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Exercise 2Deglutition 2pembrolizumab 1durvalumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Tablets 1Standard of Care 1Respiratory Function Tests 1Resistance Training 1Range of Motion, Articular 1Radiotherapy 1Pravastatin 1Nivolumab 1Niacinamide 1Lead 1Immunotherapy 1Hyaluronic Acid 1Electromyography 1Drug Therapy 1Dexamethasone 1Cisplatin 1Cetuximab 1Calcium Dobesilate 1Amifostine 1Aerosols 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Deglutition Disorders × Amifostine × Head & Neck × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡